Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates

Journal of Infection and Chemotherapy

Volumn 12, Issue 4, 2006, Pages 195-202

  Kobashi, Yoshihiro ^a   Yoshida, Kouichiro ^a   Miyashita, Naoyuki ^a   Niki, Yoshihito ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Antimicrobial susceptibility; Clinical efficacy; Drug sensitivity testing; Mycobacterium avium complex; Pulmonary disease

Indexed keywords

ETHAMBUTOL; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; ERADICATION THERAPY; FEMALE; HUMAN; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM;

EID: 33748331509     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-006-0457-8     Document Type: Article

References (16)

1. M Sakatani 1994 Nontuberculous mycobacteriosis (NTM) in Japan-epidemiologic and clinical study Kekkaku 69 119 24
2. CR Horsburgh UG Mason LB Heifets K Southwick J Labreque MD Iseman 1987 Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results on in vitro susceptibility testing Am Rev Respir Dis 135 418 21
3. RJ Wallace BA Brown DE Griffith WM Girard DT Murphy GO Onyi 1994 Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease Am J Resp Crit Care Med 149 1335 41
4. RJ Wallace Jr BA Brown DE Griffith WM Girard DT Murphy 1996 Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients Am J Resp Crit Care Med 153 1766 72
5. American Thoracic Society 1997 Diagnosis and treatment of disease caused by nontuberculous mycobacteria Am J Respir Crit Care Med 156 S1 S25
6. Japanese Society for Tuberculosis 1998 Treatment of nontuberculous mycobacteria Kekkaku 73 588 605
7. E Tanaka T Kimoto K Tsuyuguchi I Watanabe H Matsumoto A Niimi 1999 Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease Am J Respir Crit Care Med 160 866 72
8. BA Brown RJ Wallace Jr GO Onyi 1992 Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system Antimicrob Agents Chemother 36 1987 90
9. RJ Wallace Jr DR Nash LC Steele V Steingrube 1986 Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth J Clin Microbiol 24 976 81
10. L Heifets N Mor J Vanderkolk 1993 Mycobacterium avium strains resistant to clarithromycin and azithromycin Antimicrob Agents Chemother 37 2364 70
11. WW Daniel 1991 Biostatistics. A foundation for analysis in the health sciences 5th ed John Wiley & Sons Toronto
12. Y Kobashi T Matsushima 2003 The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex disease Intern Med 42 670 5
13. H Tomioka C Sano K Sato T Shimizu 2002 Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex Int J Antimicrob Agents 19 139 45
14. JC Rodriguez L Cebrian M Lopez M Ruiz G Royo 2005 Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration Int J Antimicrob Agents 25 221 5
15. GL Woods BA Williams-Bouyer RJ Wallace Jr BA Brown-Elliott FG Witebsky PS Conville 2003 Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex J Clin Micro 41 627 31
16. T Horiguchi R Kondo J Miyazaki M Shiga M Sugiyama M Handa 2004 Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection J Intern Med Res 32 530 539